Bananas, no I didn't get a personal response. Perhaps this announcement is supposed to address the arisen issues, but it certainly seems like a cover up not to disclose cost estimates like EVERY single other company that announces scope study results to the market.
Pilatus, all scoping studies are conceptual. Feasibility studies are material. Ask anyone in the industry and they will confirm this.
Compared to its peers, this stock really is as cheap as they come, so fingers crossed the board knows what they're doing here! I wouldn't want to see them make a mockery of a golden opportunity to excel. There's no doubt that the resource is impressive, but the board are either going to live or die by the manner in which this study has been disclosed to the market.
NMR Price at posting:
3.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)